The kappa opioid receptor agonists not only provide analgesia but also suppress addiction, whereas the delta opioid receptor agonists possess a strong analgesic activity as well as anti-anxiety, anti-depression, and organ protection [30, 31]. This evidence concerns the gene OPRK1 and depressive disorder.